Search Result
Results for "
peptide modification
" in MedChemExpress (MCE) Product Catalog:
46
Biochemical Assay Reagents
Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-114350
-
|
Fluorescent Dye
|
Others
|
BDP FL maleimide is a thiol-reactive dye (Ex: 503 nm; Em: 509 nm). BDP FL maleimide can be used for protein labeling, peptide modification, and can replace fluorescein (FAM) for microscopy .
|
-
-
- HY-P3581
-
|
Potassium Channel
|
Neurological Disease
|
PE 22-28 is a TREK-1 inhibitor with IC50 value of 0.12 nM. PE 22-28 also is a 7 amino-acid peptide that is used as a core sequence for preparing analogs by chemical modifications and also by substitution of amino-acids. PE 22-28 can be used for the research of depression .
|
-
-
- HY-P5533
-
|
Biochemical Assay Reagents
|
Cancer
|
CRT, an iron peptide mimic, can bind to apo-transferrin (apo-Tf). CRT can be used to modify nanoparticles, and enhances drug delivery efficiency .
|
-
-
- HY-118093
-
|
Drug Metabolite
|
Others
|
N-benzoyl-L-aspartic acid, a major metabolite of benzyl glucosinolate, can be used for modification of peptides or proteins .
|
-
-
- HY-138982
-
-
-
- HY-P10499
-
|
CaMK
|
Others
|
[Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) is a modified fragment of calcium/calmodulin-dependent protein kinase II that contains the active domain of CaMKII and has an alanine substitution at position 286. [Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) can be used to develop more potent CaMKII inhibitors .
|
-
-
- HY-P10533
-
|
Biochemical Assay Reagents
|
Others
|
Cysteine peptide is a heptapeptide containing a cysteine residue whose thiol group makes it susceptible to a range of oxidative modifications. Cysteine peptide is used to detect the skin sensitization potential of chemicals including cosmetic ingredients .
|
-
-
- HY-W1048512A
-
-
-
- HY-174959A
-
-
-
- HY-W1048512B
-
-
-
- HY-174959H
-
-
-
- HY-W1048855D
-
-
-
- HY-174959C
-
-
-
- HY-W1048512C
-
-
-
- HY-W1048855C
-
-
-
- HY-174959B
-
-
-
- HY-W1048855B
-
-
-
- HY-W1048855A
-
-
-
- HY-174959
-
-
-
- HY-174959D
-
-
-
- HY-W1048512D
-
-
-
- HY-174959E
-
-
-
- HY-W1048851A
-
-
-
- HY-W1048851D
-
-
-
- HY-W1048851B
-
-
-
- HY-W1048851C
-
-
-
- HY-174358A
-
|
Biochemical Assay Reagents
|
Others
|
HOOC-PEG-COOH (MW 2000) has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG-COOH (MW 2000) is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
-
- HY-174358B
-
|
Biochemical Assay Reagents
|
Others
|
HOOC-PEG-COOH (MW 3400) has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG-COOH (MW 3400) is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
-
- HY-174358C
-
|
Biochemical Assay Reagents
|
Others
|
HOOC-PEG-COOH (MW 5000) has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG-COOH (MW 5000) is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
-
- HY-174358
-
|
Biochemical Assay Reagents
|
Others
|
HOOC-PEG-COOH (MW 1000) has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG-COOH (MW 1000) is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
-
- HY-174358D
-
|
Biochemical Assay Reagents
|
Others
|
HOOC-PEG-COOH (MW 10000) has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG-COOH (MW 10000) is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
-
- HY-174358E
-
|
Biochemical Assay Reagents
|
Others
|
HOOC-PEG-COOH (MW 20000) has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG-COOH (MW 20000) is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
-
- HY-174358H
-
|
Biochemical Assay Reagents
|
Others
|
HOOC-PEG-COOH (MW 40000) has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG-COOH (MW 40000) is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
-
- HY-W1048511
-
2-Arm PEG-Amine (MW 5000)
|
Biochemical Assay Reagents
|
Others
|
2-Arm PEG-NH2 (MW 5000) (2-Arm PEG-Amine (MW 5000)) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
-
- HY-W1048511A
-
2-Arm PEG-Amine (MW 20000)
|
Biochemical Assay Reagents
|
Others
|
2-Arm PEG-NH2 (MW 20000) (2-Arm PEG-Amine (MW 20000)) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
-
- HY-W1048511C
-
2-Arm PEG-Amine (MW 10000)
|
Biochemical Assay Reagents
|
Others
|
2-Arm PEG-NH2 (MW 10000) (2-Arm PEG-Amine (MW 10000)) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
-
- HY-118093R
-
|
Drug Metabolite
|
Others
|
N-benzoyl-L-aspartic acid (Standard) is the analytical standard of N-benzoyl-L-aspartic acid. This product is intended for research and analytical applications. N-benzoyl-L-aspartic acid, a major metabolite of benzyl glucosinolate, can be used for modification of peptides or proteins .
|
-
-
- HY-W1048511B
-
2-Arm PEG-Amine (MW 40000)
|
Biochemical Assay Reagents
|
Others
|
2-Arm PEG-NH2 (MW 40000) (2-Arm PEG-Amine (MW 40000)) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
-
- HY-P1191
-
TI-JIP; JIP-1 peptide; JIPtide
|
JNK
|
Others
|
JIP-1(153-163) (TI-JIP) is a peptide inhibitor of c-JNK, based on residues 153-163 of JNK-interacting protein-1 (JIP-1) (Modifications: Phe-11 = C-terminal amide) .
|
-
-
- HY-P2255
-
|
Histone Demethylase
|
Others
|
H3K4(Me) (1-20), a histone peptide. H3K4me is an intricately regulated posttranslational modification, which is broadly associated with enhancers and promoters of actively transcribed genomic loci .
|
-
-
- HY-P1242B
-
|
Drug Derivative
|
Inflammation/Immunology
|
NEP(1-40), N-terminal uncapped is a NEP(1-40) (HY-P1242) analog without the acetylation modification at the N-terminal. NEP(1-40) is a Nogo-66 receptor (NgR) antagonist peptide .
|
-
-
- HY-174809A
-
|
Biochemical Assay Reagents
|
Others
|
6-Arm-PEG-Mal (MW 600) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
-
- HY-174809E
-
|
Biochemical Assay Reagents
|
Others
|
6-Arm-PEG-Mal (MW 5000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
-
- HY-174809H
-
|
Biochemical Assay Reagents
|
Others
|
6-Arm-PEG-Mal (MW 10000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
-
- HY-174809
-
|
Biochemical Assay Reagents
|
Others
|
6-Arm-PEG-Mal (MW 400) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
-
- HY-174809C
-
|
Biochemical Assay Reagents
|
Others
|
6-Arm-PEG-Mal (MW 2000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
-
- HY-174809D
-
|
Biochemical Assay Reagents
|
Others
|
6-Arm-PEG-Mal (MW 3400) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
-
- HY-P1191A
-
TI-JIP TFA; JIP-1 peptide TFA; JIPtide TFA
|
JNK
|
Others
|
JIP-1(153-163) TFA (TI-JIP TFA) is a peptide inhibitor of c-JNK, based on residues 153-163 of JNK-interacting protein-1 (JIP-1) (Modifications: Phe-11 = C-terminal amide) .
|
-
-
- HY-174809B
-
|
Biochemical Assay Reagents
|
Others
|
6-Arm-PEG-Mal (MW 1000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
-
- HY-107783
-
|
Others
|
Cancer
|
Sulfo-GMBS is a cross-linking agent widely used in chemical modification and coupling reactions of proteins and peptides. Among the amine-sulfhydryl cross-linkers, Sulfo-GMBS generated the largest number of cross-links and covered most of the cross-links that were identified with AMAS and GMBS .
|
-
- HY-W102456
-
L-4-Acetylphenylalanine
|
Biochemical Assay Reagents
Amino Acid Derivatives
|
Others
|
H-Phe(4-Ac)-OH (L-4-Acetylphenylalanine) is a keto-amino acid that can be converted from α-keto acids containing an acetyl group. H-Phe(4-Ac)-OH can be added to the amber position to form mutant Z-domain proteins. H-Phe(4-Ac)-OH is used as a functional amino acid in peptide modification to achieve chemical bonding between peptides and solid surfaces .
|
-
- HY-P2258
-
|
Histone Methyltransferase
|
Others
|
Histone H3 (1-34) is a peptide derived from human histone isotype 3.1. Histones are the main protein components of eukaryotic chromatin. Histone variants and histone modifications modulate chromatin structure, ensuring the precise operation of cellular processes associated with genomic DNA .
|
-
- HY-W591618A
-
4-Arm-PEG-Mal (MW 400)
|
Biochemical Assay Reagents
|
Others
|
4-Arm-PEG-Maleimide (MW 400) (4-Arm-PEG-Mal (MW 400)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-W591618D
-
4-Arm-PEG-Mal (MW 3400)
|
Biochemical Assay Reagents
|
Others
|
4-Arm-PEG-Maleimide (MW 3400) (4-Arm-PEG-Mal (MW 3400)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-W591618B
-
4-Arm-PEG-Mal (MW 600)
|
Biochemical Assay Reagents
|
Others
|
4-Arm-PEG-Maleimide (MW 600) (4-Arm-PEG-Mal (MW 600)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-W591465
-
4-Arm-PEG-Mal (MW 2000)
|
Biochemical Assay Reagents
|
Others
|
4-Arm-PEG-Maleimide (MW 2000) (4-Arm-PEG-Mal (MW 2000)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-W591618C
-
4-Arm-PEG-Mal (MW 1000)
|
Biochemical Assay Reagents
|
Others
|
4-Arm-PEG-Maleimide (MW 1000) (4-Arm-PEG-Mal (MW 1000)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-D1568
-
|
Fluorescent Dye
|
Others
|
Sulfo-Cy7.5 NHS ester is a near infrared water soluble hydrophilic dye, also is an NHS ester for the modification of amine groups. Sulfo-Cy7.5 NHS ester contains a trimeth ylene bridge and has a linker arm for its attachment to proteins, peptides, and other molecules. Sulfo-Cy7.5 NHS ester can be used for the research of NIR imaging applications .
|
-
- HY-106994A
-
YM598
|
Endothelin Receptor
|
Cardiovascular Disease
Inflammation/Immunology
Cancer
|
Nebentan potassium (YM598) is a potent, selective and orally active non-peptide endothelin ETA receptor antagonist through the modification of Bosentan (HY-A0013). Nebentan potassium inhibits [ 125I] endothelin-1 binding to cloned human endothelin ETA and ETB receptor, with Ki of 0.697 nM and 569 nM, respectively . YM598 can ameliorate the progression of cor pulmonale and myocardial infarction in vivo .
|
-
- HY-106994
-
YM598 free base
|
Endothelin Receptor
|
Cardiovascular Disease
Inflammation/Immunology
Cancer
|
Nebentan (YM598 free base) is a potent, selective and orally active non-peptide endothelin ETA receptor antagonist through the modification of Bosentan (HY-A0013). Nebentan inhibits [ 125I] endothelin-1 binding to cloned human endothelin ETA and ETB receptor, with Ki of 0.697 nM and 569 nM, respectively . YM598 can ameliorate the progression of cor pulmonale and myocardial infarction in vivo .
|
-
- HY-D1568A
-
|
Fluorescent Dye
|
Others
|
Sulfo-Cy7.5 NHS ester tripotassium is a near infrared water soluble hydrophilic dye, also is an NHS ester for the modification of amine groups. Sulfo-Cy7.5 NHS ester tripotassium contains a trimeth ylene bridge and has a linker arm for its attachment to proteins, peptides, and other molecules. Sulfo-Cy7.5 NHS ester tripotassium can be used for the research of NIR imaging applications .
|
-
- HY-174961C
-
Fmoc-NH-PEG-Mal (MW 5000)
|
Biochemical Assay Reagents
|
Others
|
Fmoc-PEG-Maleimide (MW 5000) (Fmoc-NH-PEG-Mal (MW 5000)) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-174961B
-
Fmoc-NH-PEG-Mal (MW 3400)
|
Biochemical Assay Reagents
|
Others
|
Fmoc-PEG-Maleimide (MW 3400) (Fmoc-NH-PEG-Mal (MW 3400)) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-174961
-
Fmoc-NH-PEG-Mal (MW 1000)
|
Biochemical Assay Reagents
|
Others
|
Fmoc-PEG-Maleimide (MW 1000) (Fmoc-NH-PEG-Mal (MW 1000)) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-P5506
-
|
Complement System
|
Others
|
C5a Receptor agonist, W5Cha (Peptide 1) is a selective complement C5a receptor (C5aR) agonist (EC50=0.2 μM), a hexapeptide derived from the C-terminus of C5a with specific amino acid modifications. C5a Receptor agonist, W5Cha is able to interact with the Arg-206 site of the C5a receptor through its C-terminal arginine, thereby activating the receptor .
|
-
- HY-174961A
-
Fmoc-NH-PEG-Mal (MW 2000)
|
Biochemical Assay Reagents
|
Others
|
Fmoc-PEG-Maleimide (MW 2000) (Fmoc-NH-PEG-Mal (MW 2000)) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-P10490
-
|
Drug Derivative
GnRH Receptor
|
Others
Cancer
|
(D-His(Bzl)6)-LHRH (1-7) free acid is a synthetic peptide compound that is a derivative of luteinizing hormone-releasing hormone (LHRH). (D-His(Bzl)6)-LHRH (1-7) free acid enhances its stability and biological activity by introducing unnatural amino acid residues at specific positions of the LHRH molecule. This modification can improve the drug's performance in the body half-life, reducing the rate at which it is rapidly metabolized and cleared, thereby enhancing its efficacy in inhibiting cell proliferation .
|
-
- HY-D2747
-
|
Fluorescent Dye
|
Others
|
BP Fluor 405 acid is a water-soluble, blue-fluorescent dye that is often used in multi-color applications, including flow cytometry and super-resolution microscopy using STORM. Its excitation is ideally suited for the 407 nm spectral line of the krypton laser or the 408 nm violet laser diode. BP Fluor 405 conjugates are pH-insensitive from pH 4 to pH 10.
The carboxylic acid of BP Fluor 405 is a reagent of choice for the preparation of custom activated esters that often are not commercially available. Examples of such activated esters include sulfo-NHS, TFP (2,3,5,6-Tetrafluorophenol), and STP (4-Sulfo-2,3,5,6-Tetrafluorophenol, Sodium Salt). Another common application for the non-activated carboxylic acid is peptide modification during solid phase synthesis, which usually requires in-situ activation with peptide coupling regents, e.g. HATU. BP Fluor 405 acid is also often used for control experiments, and for calibration.
|
-
- HY-151829
-
|
ADC Linker
|
Others
|
Fmoc-L-Asn(EDA-N3)-OH is a click chemistry reagent containing an azide group. This building block is reported in literature for the modification of Amanitin via Click Chemistry. Alpha-Amanitin is the deadliest member of the amatoxin peptide family produced by the death-cap mushroom A. phalloides. It is an orally available, rigid, bicyclic octapeptide and one of the most lethal known natural products (LD50 = 50-100 μg/kg) acting as highly selective allosteric inhibitor of the RNA polymerase II . It contains an azide group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing alkyne groups. It can also undergo ring strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.
|
-
Cat. No. |
Product Name |
Type |
-
- HY-114350
-
|
Fluorescent Dyes/Probes
|
BDP FL maleimide is a thiol-reactive dye (Ex: 503 nm; Em: 509 nm). BDP FL maleimide can be used for protein labeling, peptide modification, and can replace fluorescein (FAM) for microscopy .
|
-
- HY-D1568
-
|
Dyes
|
Sulfo-Cy7.5 NHS ester is a near infrared water soluble hydrophilic dye, also is an NHS ester for the modification of amine groups. Sulfo-Cy7.5 NHS ester contains a trimeth ylene bridge and has a linker arm for its attachment to proteins, peptides, and other molecules. Sulfo-Cy7.5 NHS ester can be used for the research of NIR imaging applications .
|
-
- HY-D1568A
-
|
Dyes
|
Sulfo-Cy7.5 NHS ester tripotassium is a near infrared water soluble hydrophilic dye, also is an NHS ester for the modification of amine groups. Sulfo-Cy7.5 NHS ester tripotassium contains a trimeth ylene bridge and has a linker arm for its attachment to proteins, peptides, and other molecules. Sulfo-Cy7.5 NHS ester tripotassium can be used for the research of NIR imaging applications .
|
-
- HY-D2747
-
|
Fluorescent Dyes/Probes
|
BP Fluor 405 acid is a water-soluble, blue-fluorescent dye that is often used in multi-color applications, including flow cytometry and super-resolution microscopy using STORM. Its excitation is ideally suited for the 407 nm spectral line of the krypton laser or the 408 nm violet laser diode. BP Fluor 405 conjugates are pH-insensitive from pH 4 to pH 10.
The carboxylic acid of BP Fluor 405 is a reagent of choice for the preparation of custom activated esters that often are not commercially available. Examples of such activated esters include sulfo-NHS, TFP (2,3,5,6-Tetrafluorophenol), and STP (4-Sulfo-2,3,5,6-Tetrafluorophenol, Sodium Salt). Another common application for the non-activated carboxylic acid is peptide modification during solid phase synthesis, which usually requires in-situ activation with peptide coupling regents, e.g. HATU. BP Fluor 405 acid is also often used for control experiments, and for calibration.
|
Cat. No. |
Product Name |
Type |
-
- HY-W1048855C
-
|
Drug Delivery
|
4-Arm PEG-SCM (MW 20000) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-W1048855B
-
|
Drug Delivery
|
4-Arm PEG-SCM (MW 10000) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-W1048512A
-
|
Drug Delivery
|
2-Arm PEG-NHS (MW 20000) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-174959A
-
|
Drug Delivery
|
6-Arm-PEG-NHS (MW 600) is a six-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-W1048512B
-
|
Drug Delivery
|
2-Arm PEG-NHS (MW 40000) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-174959H
-
|
Drug Delivery
|
6-Arm-PEG-NHS (MW 10000) is a six-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-W1048855D
-
|
Drug Delivery
|
4-Arm PEG-SCM (MW 40000) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-174959C
-
|
Drug Delivery
|
6-Arm-PEG-NHS (MW 2000) is a six-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-W1048512C
-
|
Drug Delivery
|
2-Arm PEG-NHS (MW 5000) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-174959B
-
|
Drug Delivery
|
6-Arm-PEG-NHS (MW 1000) is a six-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-W1048855A
-
|
Drug Delivery
|
4-Arm PEG-SCM (MW 5000) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-174959
-
|
Drug Delivery
|
6-Arm-PEG-NHS (MW 400) is a six-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-174959D
-
|
Drug Delivery
|
6-Arm-PEG-NHS (MW 3400) is a six-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-W1048512D
-
|
Drug Delivery
|
2-Arm PEG-NHS (MW 10000) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-174959E
-
|
Drug Delivery
|
6-Arm-PEG-NHS (MW 5000) is a six-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-W1048851A
-
|
Drug Delivery
|
4-Arm PEG-MAL (MW 5000) can be used for site-specific protein and peptide modification and can be used for drug delivery .
|
-
- HY-W1048851D
-
|
Drug Delivery
|
4-Arm PEG-MAL (MW 40000) can be used for site-specific protein and peptide modification and can be used for drug delivery .
|
-
- HY-W1048851B
-
|
Drug Delivery
|
4-Arm PEG-MAL (MW 10000) can be used for site-specific protein and peptide modification and can be used for drug delivery .
|
-
- HY-W1048851C
-
|
Drug Delivery
|
4-Arm PEG-MAL (MW 205000) can be used for site-specific protein and peptide modification and can be used for drug delivery .
|
-
- HY-174358A
-
|
Drug Delivery
|
HOOC-PEG-COOH (MW 2000) has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG-COOH (MW 2000) is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
- HY-174358B
-
|
Drug Delivery
|
HOOC-PEG-COOH (MW 3400) has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG-COOH (MW 3400) is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
- HY-174358C
-
|
Drug Delivery
|
HOOC-PEG-COOH (MW 5000) has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG-COOH (MW 5000) is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
- HY-174358
-
|
Drug Delivery
|
HOOC-PEG-COOH (MW 1000) has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG-COOH (MW 1000) is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
- HY-174358D
-
|
Drug Delivery
|
HOOC-PEG-COOH (MW 10000) has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG-COOH (MW 10000) is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
- HY-174358E
-
|
Drug Delivery
|
HOOC-PEG-COOH (MW 20000) has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG-COOH (MW 20000) is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
- HY-174358H
-
|
Drug Delivery
|
HOOC-PEG-COOH (MW 40000) has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG-COOH (MW 40000) is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
- HY-W1048511
-
2-Arm PEG-Amine (MW 5000)
|
Drug Delivery
|
2-Arm PEG-NH2 (MW 5000) (2-Arm PEG-Amine (MW 5000)) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-W1048511A
-
2-Arm PEG-Amine (MW 20000)
|
Drug Delivery
|
2-Arm PEG-NH2 (MW 20000) (2-Arm PEG-Amine (MW 20000)) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-W1048511C
-
2-Arm PEG-Amine (MW 10000)
|
Drug Delivery
|
2-Arm PEG-NH2 (MW 10000) (2-Arm PEG-Amine (MW 10000)) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-W1048511B
-
2-Arm PEG-Amine (MW 40000)
|
Drug Delivery
|
2-Arm PEG-NH2 (MW 40000) (2-Arm PEG-Amine (MW 40000)) is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .
|
-
- HY-174809A
-
|
Drug Delivery
|
6-Arm-PEG-Mal (MW 600) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-174809E
-
|
Drug Delivery
|
6-Arm-PEG-Mal (MW 5000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-174809H
-
|
Drug Delivery
|
6-Arm-PEG-Mal (MW 10000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-174809
-
|
Drug Delivery
|
6-Arm-PEG-Mal (MW 400) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-174809C
-
|
Drug Delivery
|
6-Arm-PEG-Mal (MW 2000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-174809D
-
|
Drug Delivery
|
6-Arm-PEG-Mal (MW 3400) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-174809B
-
|
Drug Delivery
|
6-Arm-PEG-Mal (MW 1000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-W591618A
-
4-Arm-PEG-Mal (MW 400)
|
Drug Delivery
|
4-Arm-PEG-Maleimide (MW 400) (4-Arm-PEG-Mal (MW 400)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-W591618D
-
4-Arm-PEG-Mal (MW 3400)
|
Drug Delivery
|
4-Arm-PEG-Maleimide (MW 3400) (4-Arm-PEG-Mal (MW 3400)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-W591618B
-
4-Arm-PEG-Mal (MW 600)
|
Drug Delivery
|
4-Arm-PEG-Maleimide (MW 600) (4-Arm-PEG-Mal (MW 600)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-W591465
-
4-Arm-PEG-Mal (MW 2000)
|
Drug Delivery
|
4-Arm-PEG-Maleimide (MW 2000) (4-Arm-PEG-Mal (MW 2000)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-W591618C
-
4-Arm-PEG-Mal (MW 1000)
|
Drug Delivery
|
4-Arm-PEG-Maleimide (MW 1000) (4-Arm-PEG-Mal (MW 1000)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-174961C
-
Fmoc-NH-PEG-Mal (MW 5000)
|
Drug Delivery
|
Fmoc-PEG-Maleimide (MW 5000) (Fmoc-NH-PEG-Mal (MW 5000)) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-174961B
-
Fmoc-NH-PEG-Mal (MW 3400)
|
Drug Delivery
|
Fmoc-PEG-Maleimide (MW 3400) (Fmoc-NH-PEG-Mal (MW 3400)) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-174961
-
Fmoc-NH-PEG-Mal (MW 1000)
|
Drug Delivery
|
Fmoc-PEG-Maleimide (MW 1000) (Fmoc-NH-PEG-Mal (MW 1000)) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
-
- HY-174961A
-
Fmoc-NH-PEG-Mal (MW 2000)
|
Drug Delivery
|
Fmoc-PEG-Maleimide (MW 2000) (Fmoc-NH-PEG-Mal (MW 2000)) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
|
Cat. No. |
Product Name |
Target |
Research Area |
-
- HY-P3581
-
|
Potassium Channel
|
Neurological Disease
|
PE 22-28 is a TREK-1 inhibitor with IC50 value of 0.12 nM. PE 22-28 also is a 7 amino-acid peptide that is used as a core sequence for preparing analogs by chemical modifications and also by substitution of amino-acids. PE 22-28 can be used for the research of depression .
|
-
- HY-P5533
-
|
Biochemical Assay Reagents
|
Cancer
|
CRT, an iron peptide mimic, can bind to apo-transferrin (apo-Tf). CRT can be used to modify nanoparticles, and enhances drug delivery efficiency .
|
-
- HY-P1191
-
TI-JIP; JIP-1 peptide; JIPtide
|
JNK
|
Others
|
JIP-1(153-163) (TI-JIP) is a peptide inhibitor of c-JNK, based on residues 153-163 of JNK-interacting protein-1 (JIP-1) (Modifications: Phe-11 = C-terminal amide) .
|
-
- HY-P2255
-
|
Histone Demethylase
|
Others
|
H3K4(Me) (1-20), a histone peptide. H3K4me is an intricately regulated posttranslational modification, which is broadly associated with enhancers and promoters of actively transcribed genomic loci .
|
-
- HY-P1242B
-
|
Drug Derivative
|
Inflammation/Immunology
|
NEP(1-40), N-terminal uncapped is a NEP(1-40) (HY-P1242) analog without the acetylation modification at the N-terminal. NEP(1-40) is a Nogo-66 receptor (NgR) antagonist peptide .
|
-
- HY-P10499
-
|
CaMK
|
Others
|
[Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) is a modified fragment of calcium/calmodulin-dependent protein kinase II that contains the active domain of CaMKII and has an alanine substitution at position 286. [Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) can be used to develop more potent CaMKII inhibitors .
|
-
- HY-P4794
-
|
Peptides
|
Others
|
Osteoblast-Adhesive Peptide is a polypeptide used for chemical modification of biomaterials. Osteoclast Adaptive Peptide increases the adhesion of osteoblasts and has potential applications in dentistry and orthopedics .
|
-
- HY-P10533
-
|
Biochemical Assay Reagents
|
Others
|
Cysteine peptide is a heptapeptide containing a cysteine residue whose thiol group makes it susceptible to a range of oxidative modifications. Cysteine peptide is used to detect the skin sensitization potential of chemicals including cosmetic ingredients .
|
-
- HY-P5514
-
Amylin (22-27) [NMeG24, NMeI26], human (IAPP)
|
Peptides
|
Others
|
NF(N-Me)GA(N-Me)IL is a biological active peptide. (This amino acids 22 to 27 fragment is a modification of the human islet amyloid polypeptide hIAPP (NFGAIL) with N-methylation of the amide bonds at G24 and I26. The introduction of two N-methyl rests in the amyloid-core-containing sequence NFGAIL converts this amyloidogenic and cytotoxic sequence into non-amyloidogenic and non-cytotoxic peptide. The peptide is able to bind with high-affinity full-length hIAPP and to inhibit its fibrillogenesis.)
|
-
- HY-P1191A
-
TI-JIP TFA; JIP-1 peptide TFA; JIPtide TFA
|
JNK
|
Others
|
JIP-1(153-163) TFA (TI-JIP TFA) is a peptide inhibitor of c-JNK, based on residues 153-163 of JNK-interacting protein-1 (JIP-1) (Modifications: Phe-11 = C-terminal amide) .
|
-
- HY-P2258
-
|
Histone Methyltransferase
|
Others
|
Histone H3 (1-34) is a peptide derived from human histone isotype 3.1. Histones are the main protein components of eukaryotic chromatin. Histone variants and histone modifications modulate chromatin structure, ensuring the precise operation of cellular processes associated with genomic DNA .
|
-
- HY-P5506
-
|
Complement System
|
Others
|
C5a Receptor agonist, W5Cha (Peptide 1) is a selective complement C5a receptor (C5aR) agonist (EC50=0.2 μM), a hexapeptide derived from the C-terminus of C5a with specific amino acid modifications. C5a Receptor agonist, W5Cha is able to interact with the Arg-206 site of the C5a receptor through its C-terminal arginine, thereby activating the receptor .
|
-
- HY-P10490
-
|
Drug Derivative
GnRH Receptor
|
Others
Cancer
|
(D-His(Bzl)6)-LHRH (1-7) free acid is a synthetic peptide compound that is a derivative of luteinizing hormone-releasing hormone (LHRH). (D-His(Bzl)6)-LHRH (1-7) free acid enhances its stability and biological activity by introducing unnatural amino acid residues at specific positions of the LHRH molecule. This modification can improve the drug's performance in the body half-life, reducing the rate at which it is rapidly metabolized and cleared, thereby enhancing its efficacy in inhibiting cell proliferation .
|
-
- HY-P10525
-
|
Peptides
|
Neurological Disease
|
MBP Ac1-9 (4Y) is a synthetic peptide derived from a fragment of myelin basic protein (MBP) that has undergone specific chemical modifications. MBP Ac1-9 (4Y) is able to form a complex with the MHC class II molecule I-Au and activate specific T cell receptor (TCR), thus playing a role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE). MBP Ac1-9 (4Y) can be used to study autoimmune diseases, especially those involving the central nervous system, such as multiple sclerosis .
|
-
- HY-K0224
-
|
MCE Amino magnetic beads (200 nm,10 mg/mL) can easily and efficiently combine with a variety of biological ligand in high loads, such as proteins, peptides, oligonucleotides, drug molecules, etc. It can be used as a good basic material for subsequent processing, adsorption, chemical modification and other follow-up processing.
|
Cat. No. |
Product Name |
|
Classification |
-
- HY-151829
-
|
|
Azide
|
Fmoc-L-Asn(EDA-N3)-OH is a click chemistry reagent containing an azide group. This building block is reported in literature for the modification of Amanitin via Click Chemistry. Alpha-Amanitin is the deadliest member of the amatoxin peptide family produced by the death-cap mushroom A. phalloides. It is an orally available, rigid, bicyclic octapeptide and one of the most lethal known natural products (LD50 = 50-100 μg/kg) acting as highly selective allosteric inhibitor of the RNA polymerase II . It contains an azide group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing alkyne groups. It can also undergo ring strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.
|
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: